一个糖尿病怀孕技术路线图:2023年诺伯特·弗林克尔奖讲座演讲
1Norwich Medical School, University of East Anglia, and Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, U.K.
Diabetes care
|February 23, 2024
概括
混合闭环 (HCL) 系统可以改善1型糖尿病 (T1D) 孕妇的血糖控制. 这些先进的系统有助于实现更严格的怀孕葡萄糖目标,减少高血糖并改善负担较小的结果.
科学领域:
- 内分泌学 在内分泌学.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 生物医学工程 生物医学工程
背景情况:
- 怀孕期间的1型糖尿病 (T1D) 需要积极的胰岛素治疗,正如Norbert Freinkel所强调的那样.
- 持续血糖监测 (CGM) 和混合闭环 (HCL) 系统为怀孕期间管理T1D提供了新的方法.
- 尽管使用了CGM,但对于许多T1D妇女来说,实现最佳妊娠葡萄糖目标仍然是一个挑战.
研究的目的:
- 评估HCL胰岛素输送系统在改善T1D孕妇的血糖控制方面的疗效.
- 评估HCL系统是否可以帮助达到严格的怀孕特定时间范围 (TIRp) 目标.
- 为了确定HCL使用对母亲和新生儿的结果以及整体怀孕经验的影响.
主要方法:
- 在患有T1D的孕妇队列中使用了CamAPS FX HCL系统.
- 血糖控制指标的比较,包括范围内的时间 (TIRp),高血糖和一夜间的TIRp,与HCL使用.
- 评估妊娠期体重增加和患者报告的担忧和工作负担经历.
主要成果:
- 使用HCL系统导致TIRp增加10.5%,一夜间TIRp增加12.3%.
- 在使用HCL系统时,高血糖减少了10.2%.
- 与3.7公斤更少的妊娠体重增加和改善的患者体验有关,与更少的担忧和工作.
结论:
- 在患有T1D的妇女中,HCL胰岛素输送系统有效地弥合了实现严格妊娠血糖目标的差距.
- 这些系统提供了显著的临床益处,包括改善血糖控制和减少妊娠期体重增加.
- 妇女,医疗保健团队和技术提供商协同使用HCL技术可以改善怀孕经验和结果.
更多相关视频
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Pathophysiology of Diabetes
935
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
935
Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
Diabetes: Symptoms, Diagnosis, and Complications
539
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
539
Oral Hypoglycemic Agents: Biguanides and Glitazones
201
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
201
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K


